Budesonide

Manufacturer
Rite Aid | Apotex Inc.
Effective date
2017-12-19
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-02 01:06:14

Label at a glance#

ProductBudesonide
Active ingredientBudesonide
Label structure11 sections

Indications and uses

Temporarily relieves these symptoms of hay fever or other upper respiratory allergies: • nasal congestion • runny nose • itchy nose • sneezing

Dosage and administration

Read insert (inside package) on how to: get a new bottle ready (primed) before first use prime bottle again if not used for two days use the spray clean the spray nozzle ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER adults and children 12 years of age and older once daily, spray 2 times into each nostril while sniffing gently once your allergy symptoms improve, reduce to 1 spray in each nostril per day CHILDREN 6 ...

Label contents#

Full prescribing information#

SPL PRODUCT DATA ELEMENTS SECTION

SPL UNCLASSIFIED SECTION

Active ingredient (in each spray)

OTC - ACTIVE INGREDIENT SECTION

Budesonide (glucocorticoid) 32 mcg

Purpose

OTC - PURPOSE SECTION

Nasal allergy symptom reliever

Uses

INDICATIONS & USAGE SECTION

Temporarily relieves these symptoms of hay fever or other upper respiratory allergies:

• nasal congestion • runny nose • itchy nose • sneezing

Warnings

WARNINGS SECTION

Do not use

OTC - DO NOT USE SECTION

  • in children under 6 years of age
  • if you have ever had an allergic reaction to any of the ingredients

Ask a doctor before use if you

OTC - ASK DOCTOR SECTION

  • have had recent nose ulcers or nose surgery
  • have had a nose injury that has not healed
  • are using a steroid medicine for asthma, allergies or skin rash
  • have an eye infection
  • have or had glaucoma or cataracts

When using this product

OTC - WHEN USING SECTION

  • the growth rate of some children may be slower
  • some symptoms may get better on the first day of treatment. It may take up to two weeks of daily use to feel the most symptom relief.
  • do not share this bottle with anyone else as this may spread germs
  • remember to tell your doctor about all the medicines you take, including this one

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • you have, or come into contact with someone who has, chickenpox, measles or tuberculosis
  • you have or develop symptoms of an infection such as persistent fever
  • you have any change in vision
  • you have severe or frequent nosebleeds

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Directions

DOSAGE & ADMINISTRATION SECTION

Read insert (inside package) on how to:
  • get a new bottle ready (primed) before first use
  • prime bottle again if not used for two days
  • use the spray
  • clean the spray nozzle

ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER

adults and children 12 years of age and older

  • once daily, spray 2 times into each nostril while sniffing gently
  • once your allergy symptoms improve, reduce to 1 spray in each nostril per day
CHILDREN 6 TO UNDER 12 YEARS OF AGE
  • the growth rate of some children may be slower while using this product. Talk to your child’s doctor if your child needs to use the spray for longer than two months a year
children 6 to under 12 years of age
  • an adult should supervise use
  • once daily, spray 1 time into each nostril while sniffing gently
  • if allergy symptoms do not improve, increase to 2 sprays in each nostril per day. Once allergy symptoms improve, reduce to 1 spray in each nostril per day
children under 6 years of age
  • do not use
  • do not use more than directed
  • if you forget a dose, do not double the next dose
  • do not spray into eyes or mouth
  • if allergy symptoms do not improve after two weeks, stop using and talk to a doctor
  • do not use for the common cold
  • shake well before each use

Other information

SPL UNCLASSIFIED SECTION

  • do not use if the safety seal labeled "sealed for your protection" is broken or missing.
  • keep package and insert. They contain important information.
  • store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Do not freeze. Protect from light.

Inactive ingredients

INACTIVE INGREDIENT SECTION

carboxymethyl cellulose sodium, dextrose anhydrous, edetate disodium dihydrate, hydrochloric acid (for pH adjustment), microcrystalline cellulose, polysorbate 80, potassium sorbate, purified water

Questions or comments?

OTC - QUESTIONS SECTION

call toll free 1-800-706-5575

Principal Display Panel - Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

CARTON LABEL - PRINCIPAL DISPLAY PANEL - 32 mcg per spray

Rite Aid

Budesonide Nasal Spray

Allergy Spray

120 sprays

Relief of:

  • Nasal Congestion
  • Runny Nose
  • Itchy Nose
  • Sneezing

Carton-labelCarton-label

Principal Display Panel - Bottle

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

BOTTLE LABEL - PRINCIPAL DISPLAY PANEL - 32 mcg per spray

Rite Aid

Budesonide Nasal Spray

Allergy Spray

120 sprays

Bottle-labelBottle-label

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
11822-6000-62022-05-18C16284748780-1ba0f9c33-2cdf-a910-e053-dadaa90a0b85Drug Facts
11822-6000-62021-01-29C16284748780-1ba0f9c33-2cdf-a910-e053-dadaa90a0b85Drug Facts

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
11822-600011822-6000-6

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A078949-002BUDESONIDEBUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-20

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-2084e616aacf4f…
2026-08-18 06:07:402026-07A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-20caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-20011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-2031067a03dcf5…
2025-08-23 18:47 UTC2025-08A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-206a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-20fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-20b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-2003ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-202680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-205bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-20d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-20d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-2079d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-20301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-201e350fbaab3a…
2024-05-31 18:47 UTC2024-05A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-208072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-205c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-205d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-204b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-2074a2ff9319b5…
2022-03-09 01:35 UTC2022-03A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-20bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-20782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-2087673890dc5c…
2021-03-12 10:30 UTC2021-03A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-205aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-208869cabd3fbd…
2020-11-12 02:37 UTC2020-11A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-20c0c555d07b60…
2019-12-14 00:12 UTC2019-12A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-203f01610625f2…
2019-09-15 20:21 UTC2019-09A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-20b00525d2431f…
2019-07-19 19:46 UTC2019-07A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-20ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-206a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-201c564ffb4f44…
2023-12-20 04:57 UTC2023-12A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-20ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-20a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-209b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-20a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-203f0d92c62455…
2023-05-13 08:27 UTC2023-05A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-20053a50430f4f…
2023-01-26 05:58 UTC2023-01A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-203bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-203a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A078949-002BUDESONIDE0.032MG/SPRAYSPRAY, METERED / NASAL2015-11-20f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
a0919e48-2839-aa40-2b7c-28adfd10967a39c0c82b-f969-f2c6-143e-3108cdb665912022-05-18WarningsExact identifier
spl set id: 39c0c82b-f969-f2c6-143e-3108cdb66591

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.